U.S. Life Sciences Stock News

On 17 February 2026, Path Robotics announced a memorandum of understanding with Huntington Ingalls Industries to explore integrating its physical AI welding technology into HII’s shipbuilding operations, targeting autonomous capability development, workforce training, and an intellectual property framework for AI-based welding systems. The partnership’s focus on AI-driven autonomous welding that can adapt to complex, real-world shipyard conditions highlights how automation could reshape...

In February 2026, Gilat Satellite Networks Ltd. reported full-year 2025 sales of US$451.66 million alongside new defense orders totaling about US$25 million from Israel’s and a European Ministry of Defense for advanced satellite communication systems. These contracts, together with management’s 2026 revenue guidance of US$500 million to US$520 million, highlight growing defense-related demand even as profitability metrics have not moved in line with the sharp increase in sales. Now we’ll...

In February 2026, Bausch Health Companies reported fourth-quarter 2025 revenue of US$2,796 million and a net loss of US$112 million, alongside full-year 2025 revenue of US$10.27 billion, net income of US$157 million, and a US$145 million goodwill impairment, while also issuing 2026 revenue guidance of US$10.63–US$10.88 billion. A day later, the company and its OraPharma dental unit marked the 25th anniversary of ARESTIN, currently the only FDA-approved locally applied antibiotic adjunct for...

In February 2026, Four Corners Property Trust reported its fourth-quarter and full-year 2025 results, with quarterly revenue of US$75.67 million and net income of US$29.44 million, and full-year revenue of US$294.13 million and net income of US$112.36 million. An interesting takeaway is that while full-year revenue and net income increased compared to the prior year, basic and diluted earnings per share from continuing operations only edged up slightly to US$1.09, highlighting the impact of...

In February 2026, Jefferies Financial Group issued multiple senior unsecured notes, including fixed- and step-up coupon bonds maturing in 2032, 2033, 2041 and 2056, to raise capital at par with modest issue discounts. The mix of long-dated, callable step-up and fixed-rate notes highlights Jefferies’ emphasis on flexible, unsecured funding across a wide range of maturities. We will now examine how this expanded use of long-dated, callable senior unsecured debt shapes Jefferies’ broader...

Universal (UVV) is back in focus after reporting third quarter and nine month results to December 31, 2025, showing lower sales and net income year on year, with no share repurchases completed. See our latest analysis for Universal. Universal’s recent earnings softness sits against a relatively steady share price, with a 90 day share price return of 3.9% and a 1 year total shareholder return of 7.26%. This suggests modest but ongoing momentum despite weaker quarterly results and inactive...

In February 2026, Weave and Planet DDS each announced new integrations of Synchrony’s CareCredit patient financing into their healthcare software platforms, while Synchrony also completed a US$750 million fixed-to-floating senior unsecured notes offering due 2032. Together, these moves deepen CareCredit’s role inside everyday healthcare workflows and give Synchrony added funding flexibility to support its embedded financing ambitions. Next, we’ll examine how embedding CareCredit into...

In February 2026, Regency Centers Corporation filed an omnibus shelf registration that covers common and preferred stock, depositary shares, warrants, purchase contracts, units, and debt securities of Regency Centers, L.P., giving it the legal framework to issue a wide range of securities as needed. This broad shelf registration expands Regency Centers’ optionality for future financing or corporate actions, which investors often watch closely for signals about potential development,...

Schneider National (SNDR) is back in focus after its latest 10-K highlighted operational results across Truckload, Intermodal, and Logistics, as well as acquisitions, debt reduction, share repurchases, and planned 2026 capital spending of $400 million to $450 million. See our latest analysis for Schneider National. At a share price of $29.31, Schneider National has seen a 35.63% 90-day share price return and a 9.1% 1-year total shareholder return, suggesting recent momentum has picked up...

Why Fabrinet (FN) is suddenly back on investors’ radar Fabrinet (FN) has jumped into focus after a 6.3% single-day move that followed quarterly results beating expectations and guidance that pointed to continued sequential growth supported by AI and data center optical demand. See our latest analysis for Fabrinet. That 6.3% 1 day share price move at a latest share price of $546.13 sits on top of a 16.97% 30 day share price return and a very large 5 year total shareholder return. Momentum has...

First BanCorp. has announced that long-serving Chief Financial Officer and Executive Vice President Orlando Berges will retire on June 30, 2026, with current Senior Vice President and Chief Accounting Officer Said Ortiz set to assume the CFO and Executive Vice President roles from July 1, 2026, following a planned transition period. The decision to elevate Ortiz, an internal leader with deep experience in the bank’s finance and control functions, signals an emphasis on continuity in...

Smurfit Westrock Plc has reported its fourth-quarter and full-year 2025 results, with quarterly sales edging up to US$7,580 million while net income fell to US$97 million, and full-year sales rising to US$31.18 billion alongside net income of US$699 million. Alongside these results, the company moved to close a paper machine and related extrusion facility in Quebec, signaling an effort to streamline its solid bleached sulfate portfolio and sharpen the competitiveness of its paperboard...

Booking Holdings (BKNG) is back in focus after Q4 2025 earnings topped revenue and adjusted EPS expectations, and management unveiled the company’s first-ever 25-for-1 stock split, which is set for early April. See our latest analysis for Booking Holdings. The Q4 beat and stock split arrive after a choppy stretch, with a 1-day share price return of 1.73% set against a 30-day share price return decline of 20.04% and a year to date share price return decline of 23.41%. Even so, the 3-year total...

What recent performance says about BioCryst Pharmaceuticals (BCRX) BioCryst Pharmaceuticals (BCRX) has been trading in a tight range, with the stock near US$7.45 after a gain of about 10% over the past week and month, yet a roughly 10% decline over the past year. See our latest analysis for BioCryst Pharmaceuticals. For BioCryst Pharmaceuticals, the recent 10.2% 7 day share price return and 9.7% 30 day share price return contrast with a 10.1% 1 year total shareholder return decline, which may...

What eBay’s Recent Performance Tells You Right Now eBay (EBAY) has been back on investors’ radars after a mixed stretch, with the stock up 3.9% over the past week but showing a 5.9% decline over the past month. Over the past 3 months, eBay has delivered an 8.9% return, while its 1 year total return stands at 28.9%. Against that backdrop, investors are weighing how the company’s current valuation lines up with its fundamentals. See our latest analysis for eBay. At a share price of $88.07,...

ICF International (ICFI) recently secured a multi million dollar contract amendment from Southern California Edison, more than tripling its role in the utility's Agricultural Energy Efficiency Program and expanding its support for regional agricultural customers. See our latest analysis for ICF International. The contract news comes after a mixed stretch for investors, with a 30 day share price return showing an 18.61% decline, a 3.05% gain over 90 days, and a 20.57% drop in 1 year total...

Chemed Corporation recently declared a quarterly cash dividend of US$0.60 per share, payable on March 13, 2026, marking its 219th consecutive quarterly payout over 54 years as a public company. On the same day, Chemed increased its share repurchase authorization by US$300 million to US$3.05 billion, underscoring ongoing use of capital returns alongside its long-running dividend program. Next, we’ll examine how Chemed’s expanded US$3.05 billion buyback authorization shapes the company’s...

In February 2026, ZoomInfo Technologies reported fourth-quarter and full-year 2025 results showing higher sales and net income, issued revenue guidance for the first quarter and full year 2026, adopted a new US$1.00 billion share repurchase program after completing US$797.88 million of prior buybacks, filed a US$100.68 million shelf registration for ESOP-related common stock, and appointed Owen Wurzbacher as Lead Independent Director. Together, these actions highlight stronger profitability,...

If you have been wondering whether Check Point Software Technologies is priced attractively right now, you are not alone. This article will walk through what the current share price might be implying about its value. The stock last closed at US$159.04, with returns of a 7.3% decline over 7 days, a 12.2% decline over 30 days, a 12.1% decline year to date, but gains of 28.1% over 3 years and 44.3% over 5 years. This performance can change how investors think about both risk and...

In February 2026, Freeport-McMoRan announced a Memorandum of Understanding with the Indonesian government to extend PT Freeport Indonesia’s Grasberg operating rights for the life of the resource, while committing to higher community support, increased exploration, and a future 12% ownership transfer to government interests at no cost in 2041. This framework reduces regulatory uncertainty around one of Freeport’s most important assets, but also locks in a lower long-term stake in its...

Why Woodward is on investors’ radar right now Woodward (WWD) has attracted fresh attention after a strong run in its share price over the past month and past 3 months, prompting investors to reassess its current valuation and growth profile. See our latest analysis for Woodward. Beyond the recent surge, Woodward’s 30-day share price return of 20.49% and 90-day share price return of 50.87% sit alongside a 1-year total shareholder return of 114.23%. This suggests momentum has been building over...

Why GeneDx’s latest earnings matter for shareholders GeneDx Holdings (WGS) just released its full year 2025 results, with revenue of US$427.54 million and a net loss of US$21.02 million, compared with a larger loss on lower revenue a year earlier. Loss per share from continuing operations was US$0.73 on both a basic and diluted basis, versus US$1.94 in the prior year. This change is likely to shape how investors reassess the stock. See our latest analysis for GeneDx Holdings. The earnings...

Recent securities class action filings against Plug Power (PLUG) and several senior executives, tied to a proposed US$1.66b Department of Energy loan and six planned hydrogen plants, have pulled legal and funding risk into sharper focus. See our latest analysis for Plug Power. Those class action filings and the recent decision to double authorized shares have come alongside a weak 30 day share price return of a 25.2% decline and a year to date share price return of a 16.1% decline, even...

Why SentinelOne (S) is getting attention now SentinelOne (S) is back on many watchlists after recent trading left the cyber security stock with a negative 1 day move and declines over the past week, month, and past 3 months. See our latest analysis for SentinelOne. The recent 1 day share price return of 4.35% decline, combined with a 90 day share price return of 17.12% decline and a 1 year total shareholder return of 41.37% decline, points to fading momentum as investors reassess growth...